- Report
- March 2024
- 200 Pages
Global
From €3723EUR$4,150USD£3,185GBP
- Drug Pipelines
- September 2026
- 150 Pages
From €3364EUR$3,750USD£2,878GBP
- Report
- September 2026
- 450 Pages
From €4486EUR$5,000USD£3,837GBP
- Report
- July 2026
- 143 Pages
From €7168EUR$7,990USD£6,132GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2691EUR$3,000USD£2,302GBP
- Report
- April 2025
- 200 Pages
Global
From €7132EUR$7,950USD£6,101GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1794EUR$2,000USD£1,535GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1794EUR$2,000USD£1,535GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2243EUR$2,500USD£1,919GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1346EUR$1,500USD£1,151GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£959GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£959GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£959GBP
- Report
- December 2024
- 30 Pages
Global
From €2916EUR$3,250USD£2,494GBP
- Report
- July 2024
- 150 Pages
Global
From €3364EUR$3,750USD£2,878GBP
- Report
- July 2024
- 150 Pages
Global
From €3364EUR$3,750USD£2,878GBP
- Report
- July 2024
- 100 Pages
Global
From €3364EUR$3,750USD£2,878GBP
- Report
- June 2024
- 200 Pages
Global
From €7132EUR$7,950USD£6,101GBP
- Report
- January 2024
- 189 Pages
Global
From €6728EUR$7,500USD£5,756GBP
- Report
- November 2023
- 30 Pages
Global
From €2467EUR$2,750USD£2,110GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more